Stock ADO ANTEOTECH LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company AnteoTech Limited

Equities

ADO

AU000000ADO8

Biotechnology & Medical Research

Market Closed - Australian S.E.
Other stock markets
 02:10:05 2024-04-29 am EDT 		5-day change 1st Jan Change
0.022 AUD -4.35% Intraday chart for AnteoTech Limited -4.35% -38.89%
Apr. 08 Anteotech Seeks to Raise AU$6 Million From Share Placement; Shares Fall 26% MT
Mar. 27 AnteoTech Receives AU$1.39 Million from Queensland Critical Minerals and Battery Technology Fund; Shares Down 3% MT

Business Summary

AnteoTech Limited is an Australia-based surface chemistry company. The principal activities of the Company consist of research, development and commercialization of technologies with surface management applications. The activities are primarily focused on the commercialization of these technologies across applications in the Life Science and Clean Energy Technology markets. Its lead product, AnteoX, provides significant improvement in anode performance and the Company has partnered with global suppliers in lithium-ion battery manufacturing. The life sciences division services the point of care and diagnostics markets from global diagnostics companies to technology developers. Its AnteoBind provides advantages in bioconjugation to rapidly speed up testing procedures and improve accuracy. It also offers bioconjugation and assay development services to assist point of care and diagnostics researchers and manufacturers in product development. It also offers ready-to-use kits.

Number of employees: 99

Sales per Business

AUD in Million2022Weight2023Weight Delta
AnteoTech IP
83.9 %
1 97.0 % 0 83.9 % -58.39%
Licence Fees and Royalties
16.1 %
0 3.0 % 0 16.1 % +153.31%

Sales per region

AUD in Million2022Weight2023Weight Delta
Asia
73.7 %
-- 0 73.7 % -
Europe
19.0 %
-- 0 19.0 % -
North America
5.7 %
-- 0 5.7 % -
Australia
1.5 %
1 100.0 % 0 1.5 % -99.26%

Managers

Managers TitleAgeSince
Nobuyoshi Joe Maeji FOU
 Founder - 08-12-31
David Radford CEO
 Chief Executive Officer - 22-10-03
Andrew Cook DFI
 Director of Finance/CFO - 23-08-27
Katrina Byrne COO
 Chief Operating Officer - 22-06-30
Geoff Cumming BRD
 Director/Board Member - 09-04-01
Friederike Graser IRC
 Investor Relations Contact - 20-10-31
Tsui Lian SAM
 Sales & Marketing - 23-03-14

Members of the board

Members of the board TitleAgeSince
Katherine Woodthorpe BRD
 Director/Board Member - 21-08-31
Glenda McLoughlin BRD
 Director/Board Member - 21-08-31
David Radford CEO
 Chief Executive Officer - 22-10-03
Geoff Cumming BRD
 Director/Board Member - 09-04-01
Ewen Crouch CHM
 Chairman 68 22-04-20

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 2,196,442,432 1,987,133,799 ( 90.47 %) 0 90.47 %

Shareholders

NameEquities%Valuation
Levenson Investments Pty Ltd.
4.521 %
99,303,101 4.521 % 2 M $
First Cape Management Pty Ltd.
2.513 %
55,195,509 2.513 % 1 M $
Fossil Super Pty Ltd.
1.553 %
34,100,000 1.553 % 823 174 $
Addison Lake Quality Hire Pty Ltd.
1.505 %
33,048,603 1.505 % 797 793 $
Geoff Cumming
1.141 %
25,067,750 1.141 % 605 135 $
Computer Visions Pty Ltd.
1.008 %
22,132,994 1.008 % 534 290 $
Derek Thomson
0.9484 %
20,830,554 0.9484 % 502 850 $
Mary Curtis
0.8931 %
19,616,230 0.8931 % 473 536 $
Peter Frederick Kemmis
0.7747 %
17,016,000 0.7747 % 410 766 $
Awo & Cao Investments Pty Ltd.
0.7505 %
16,483,571 0.7505 % 397 913 $

Company contact information

AnteoTech Ltd.

Brisbane Technology Park 26 Brandl Street

4113, Eight Mile Plains

+

http://www.anteotech.com
address AnteoTech Limited(ADO)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Sales per Business

Sales per region

Annual profits - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
ANTEOTECH LIMITED Stock AnteoTech Limited
-38.89% 36.13M
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+2.09% 42.75B
LONZA GROUP AG Stock Lonza Group AG
+47.70% 41.61B
MODERNA, INC. Stock Moderna, Inc.
+11.69% 41.34B
CELLTRION, INC. Stock Celltrion, Inc.
-12.36% 26.59B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+8.29% 25.49B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-23.03% 18.12B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+30.85% 12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-1.44% 11.76B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+8.47% 11B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. ADO Stock
  4. Company AnteoTech Limited